PLUS THERAPEUTICS, Inc. Series S Warrant
PSTVZ
PSTVZ was delisted on the 26th of May, 2020.
6 hedge funds and large institutions have $3K invested in PLUS THERAPEUTICS, Inc. Series S Warrant in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.
14% less funds holding
Funds holding: 7 → 6 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less capital invested
Capital invested by funds: $3.56M → $3K (-$3.56M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UB
UMB Bank
Kansas City,
Missouri
|
+$84 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$3.55M |
| 2 |
JG
Jefferies Group
New York
|
-$6K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$543 |
PSTVZ Hedge Fund Activity: Q4 2019 in Review
6 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in PLUS THERAPEUTICS, Inc. Series S Warrant (PSTVZ) for Q4 2019, worth a combined $3K — down 100% from $3.56M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PSTVZ and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest buyer was UMB Bank, opening a new position worth an estimated $84. The largest seller was Anson Funds Management, exiting entirely with an estimated $3.55M sold.
- 6 institutional investors held PLUS THERAPEUTICS, Inc. Series S Warrant (PSTVZ) as of Q4 2019, down from 7 in Q3 2019.
- Funds reported $3K of PLUS THERAPEUTICS, Inc. Series S Warrant stock for Q4 2019, down 100% quarter-over-quarter.
- 1 fund opened new PLUS THERAPEUTICS, Inc. Series S Warrant positions in Q4 2019 and 2 closed out, a net change of -1 holder.
- The largest PLUS THERAPEUTICS, Inc. Series S Warrant buyer in Q4 2019 was UMB Bank, an estimated $84 added.
- The largest PLUS THERAPEUTICS, Inc. Series S Warrant seller in Q4 2019 was Anson Funds Management, an estimated $3.55M sold.
Based on aggregated 13F filings for Q4 2019.